Eli Lilly and Company (LLY) Set to Launch Oral Obesity Drug in Q2, Reuters Reports

Eli Lilly and Company (NYSE:LLY) is one of the top stocks that will make you rich in 10 years. Eli Lilly and Company (LLY) Set to Launch Oral Obesity Drug in Q2, Reuters Reports Reuters reported on March 2 that Eli Lilly and Company (NYSE:LLY) CFO ‌Lucas Montarce stated that the company is making preparations to launch its new oral obesity drug, orforglipron, in the United ​States as early as the second quarter of ​this year once it gets approval from the ⁠Food and Drug Administration. The company furt ...